As of 2025-10-19, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (401.91) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -110.4%.
The range of the Relative Valuation is (388.18) - (470.04) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 19.2x | 16.0x |
| Forward P/E multiples | 15.8x - 19.8x | 16.8x |
| Fair Price | (388.18) - (470.04) | (401.91) |
| Upside | -110.0% - -112.2% | -110.4% |
| Date | P/E |